Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity

Molecular Medicine

Volumn 5, Issue 9, 1999, Pages 606-616

  D'Angelica, M ^a   Tung, C ^a   Allen, P ^a   Halterman, M ^a   Delman, K ^a   Delohery, T ^a   Klimstra, D ^a   Brownlee, M ^a   Federoff, H ^a   Fong, Y ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL ADHESION; CELL PROLIFERATION; CELL SURFACE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; LIVER CELL CARCINOMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; TUMOR IMMUNITY;

EID: 0033276626     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402073     Document Type: Article

References (50)

1. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion
2. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1
3. Adhesion receptors of the immune system
4. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region: Induction by cytokines and phorbol ester
5. Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)
6. Analysis of cytotoxic activity of the CD4 positive T lymphocytes generated by local immunotherapy
7. Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: Importance of ICAM-1 in binding and post-binding events
8. Dependency on intercellular adhesion molecule recognition and local interleukin-2 provision in generation of a in vivo CD8 positive T-cell immune response to murine myeloid leukemia
9. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity
10. Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells
11. Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro
12. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance
13. Supergene families meet in the immune system
14. Enhanced expression of ICAM-1 in a murine fibrosarcoma reduces tumor growth rate
15. Xenogeneic ICAM-1 gene transfer suppresses tumorigenicity and generates protective antitumor immunity
16. Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector
17. Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy
18. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology
19. Rapid and efficient gene transfer in human hepatocytes by herpes viral vectors
20. The use of HSV-1 vectors to introduce heterologous genes into neurons: Implications for gene therapy
21. Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon
22. Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: Implications for autologous vaccine production
23. Simple colorimetric cell-cell adhesion assay using MTT-stained leukemia cells
24. Preparation of human mononuclear cell populations and subpopulations
25. Interleukin-2 therapy of human cancer: Potential benefits versus toxicity
26. Cardiorespiratory effects of immunotherapy with interleukin-2
27. Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene
28. Interleukin 2-dependant activation of tumor specific cytotoxic T lymphocytes in vivo
29. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
30. In vivo priming of two distinct antitumor effector populations: The role of MHC class I expression
31. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
32. Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells
33. Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumors
34. Regression of bladder tumors in mice treated with interleukin 2 gene modified tumor cells
35. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants
36. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
37. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma
38. Tumor rejection after direct costimulation of CD8 positive cells by B7-transfected melanoma cells
39. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules
40. Costimulation of antitumor immunity by the B7 conterrecptor for the T lymphocyte molecules CD28 and CTLA-4
41. Gene therapy for cancer: What have we done and where are we going?
42. The role of ICAM-1 in tumor development
43. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α
44. The role of ICAM expression in immunity and disease
45. Immunosuppressive effect of shedding intercellular adhesion molecule 1 antigen on cell-mediated cytotoxicity against tumor cells
46. Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis
47. Construction and characterization of a recombinant vaccinia virus expressing murine intercellular adhesion molecule-1: Induction and potnetiation of anti-tumor responses
48. Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector
49. High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer
50. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone